These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 35497510)
41. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. Kilianski A; Mielech AM; Deng X; Baker SC J Virol; 2013 Nov; 87(21):11955-62. PubMed ID: 23986593 [TBL] [Abstract][Full Text] [Related]
42. Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Chou CY; Chien CH; Han YS; Prebanda MT; Hsieh HP; Turk B; Chang GG; Chen X Biochem Pharmacol; 2008 Apr; 75(8):1601-9. PubMed ID: 18313035 [TBL] [Abstract][Full Text] [Related]
43. Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19. AlAjmi MF; Azhar A; Owais M; Rashid S; Hasan S; Hussain A; Rehman MT J Biomol Struct Dyn; 2021 Oct; 39(17):6676-6688. PubMed ID: 32729392 [TBL] [Abstract][Full Text] [Related]
45. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. Barretto N; Jukneliene D; Ratia K; Chen Z; Mesecar AD; Baker SC J Virol; 2005 Dec; 79(24):15189-98. PubMed ID: 16306590 [TBL] [Abstract][Full Text] [Related]
46. A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2. Singh E; Jha RK; Khan RJ; Kumar A; Jain M; Muthukumaran J; Singh AK Comput Biol Chem; 2022 Aug; 99():107721. PubMed ID: 35835027 [TBL] [Abstract][Full Text] [Related]
47. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591 [TBL] [Abstract][Full Text] [Related]
48. Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study. Ismail MI; Ragab HM; Bekhit AA; Ibrahim TM Comput Biol Med; 2021 Apr; 131():104295. PubMed ID: 33662683 [TBL] [Abstract][Full Text] [Related]
49. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease. Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058 [TBL] [Abstract][Full Text] [Related]
50. Large-Scale Virtual Screening for the Discovery of SARS-CoV-2 Papain-like Protease (PLpro) Non-covalent Inhibitors. Garland O; Ton AT; Moradi S; Smith JR; Kovacic S; Ng K; Pandey M; Ban F; Lee J; Vuckovic M; Worrall LJ; Young RN; Pantophlet R; Strynadka NCJ; Cherkasov A J Chem Inf Model; 2023 Apr; 63(7):2158-2169. PubMed ID: 36930801 [TBL] [Abstract][Full Text] [Related]
51. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2. Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828 [TBL] [Abstract][Full Text] [Related]
52. Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic. Muteeb G; Alshoaibi A; Aatif M; Rehman MT; Qayyum MZ Appl Biol Chem; 2020; 63(1):79. PubMed ID: 33251389 [TBL] [Abstract][Full Text] [Related]
53. Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies. Ali Dahhas M; M Alkahtani H; Malik A; Almehizia AA; Bakheit AH; Akber Ansar S; AlAbdulkarim AS; S Alrasheed L; Alsenaidy MA Saudi Pharm J; 2023 Feb; 31(2):228-244. PubMed ID: 36540698 [TBL] [Abstract][Full Text] [Related]
54. Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study. Tan Q; Duan L; Ma Y; Wu F; Huang Q; Mao K; Xiao W; Xia H; Zhang S; Zhou E; Ma P; Song S; Li Y; Zhao Z; Sun Y; Li Z; Geng W; Yin Z; Jin Y Bioorg Chem; 2020 Nov; 104():104257. PubMed ID: 32927129 [TBL] [Abstract][Full Text] [Related]
55. Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases. Sivakumar D; Stein M Biomolecules; 2021 May; 11(6):. PubMed ID: 34071582 [TBL] [Abstract][Full Text] [Related]
56. Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay. Narayanan A; Narwal M; Majowicz SA; Varricchio C; Toner SA; Ballatore C; Brancale A; Murakami KS; Jose J Commun Biol; 2022 Feb; 5(1):169. PubMed ID: 35217718 [TBL] [Abstract][Full Text] [Related]
57. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2. Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632 [TBL] [Abstract][Full Text] [Related]
58. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232 [TBL] [Abstract][Full Text] [Related]
59. Stigmastane-type steroid saponins from the leaves of Van PP; Ngo Van H; Quang MB; Duong Thanh N; Nguyen Van D; Thanh TD; Tran Minh N; Thi Thu HN; Quang TN; Thao Do T; Thanh LP; Do Thi Thu H; Le Tuan AH Nat Prod Res; 2024; 38(4):601-606. PubMed ID: 36924396 [TBL] [Abstract][Full Text] [Related]
60. Identification of SARS-CoV-2 PLpro and 3CLpro human proteome substrates using substrate phage display coupled with protein network analysis. Zhao K; Li Y; Guo M; Ma L; Dang B J Biol Chem; 2023 Jun; 299(6):104831. PubMed ID: 37201587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]